• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB 1.89% 5.2¢

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged... NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company’s product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body’s innate immune response to cell injury. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NSB 22/04/24 28 8.7K
22/04/24 Last post  ozz1 Comments Created with Sketch.  28  Views Created with Sketch.  8.7K 
NSB 19/04/24 28 6.9K
19/04/24 Last post  ozz1 Comments Created with Sketch.  28  Views Created with Sketch.  6.9K 
NSB
emtinb close to glaucoma nerve cure
19/04/24 1 376
19/04/24 Last post  TopGun1 Comments Created with Sketch.  1  Views Created with Sketch.  376 
NSB 08/04/24 0 226
08/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  226 
NSB 07/04/24 23 4.2K
07/04/24 Last post  tuts Comments Created with Sketch.  23  Views Created with Sketch.  4.2K 
NSB 21:11 15 3.8K
21:11 Last post  TopGun1 Comments Created with Sketch.  15  Views Created with Sketch.  3.8K 
NSB 09/02/24 2 1.1K
09/02/24 Last post  Meme68 Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
NSB 15/01/24 0 346
15/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  346 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - NSB
08 Apr 12:04
 
Appointment of Executive Director & FDA Pre-Ind Meeting
02 Apr 09:26
 
NSB Receives A$2.2M Research & Development Tax Refund
20 Mar 09:39
 
Half Yearly Report and Accounts
27 Feb 17:43
 
Company Secretary Appointment/Resignation
06 Feb 09:52
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 09:55
 
View More arrow Created with Sketch.
(20min delay)
Last
5.2¢
Change
-0.001(1.89%)
Mkt cap ! $7.519M
Open High Low Value Volume
5.3¢ 5.3¢ 5.1¢ $6.67K 128.1K

Buyers (Bids)

No. Vol. Price($)
1 11883 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 9201 2
View Market Depth
Last trade - 16.10pm 25/04/2024 (20 minute delay) ?
Last
5.2¢
  Change
-0.001 ( 1.89 %)
Open High Low Volume
5.3¢ 5.3¢ 5.2¢ 21420
Last updated 10.44am 25/04/2024 ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.